Abiopharma

🔍 Angotti Vincent J. (Executive)

Company: TALPHERA, INC. (TLPH)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 213,310 shares of Common Stock at $0.586 per share (Direct)
  Date: 2026-03-13 | Code: P | equity_swap_involved: 0 | shares_owned_after: 800,705.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On March 31, 2025, Talphera (the "Issuer") entered into a securities purchase agreement with the Reporting Person and certain other institutional investors (the "PIPE"). The Reporting Person purchased shares in the closing of the third tranche of the PIPE conducted by the Issuer.
• F2: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.